Abstract:Microglia are the resident surveillance cells in the CNS, and are involved in shaping neuronal plasticity. Previous studies show that hypertension is associated with neuroinflammation. Interference of neuroinflammation by targeting microglia can inhibit or attenuate hypertension. To investigate the phenotypic changes of microglia during hypertension, we compared the profiles of microglia dissociated from normotensive and Ang II-induced hypertensive mice by flow cytometry. We found significant increases in the expression of CD89 (76%), CCR7 (52%), IFNγR (150%), MHC II (85%), CCR2 (51%), IL-4R (164%), mannose receptor (61%) and CD36 (60%) in Ang II microglia compared to the controls. To understand whether the microglial activation has a direct effect on blood pressure, we utilized microglia adoptive transfer strategy via intracerebroventricular (ICV) injection and then examined the blood pressure responses. Mouse microglial cell line, N9, was stimulated in groups as follows: 1) medium control, 2) 10 ng/ml LPS, 3)10 ng/ml LPS + 100 μM minocycline. After 6 hr treatment, half a million N9 cells were transferred into mice via ICV injection. Twenty-four hr later, the recipient mice were anesthetized, cannulated and positioned on the stereotaxic frame. The baseline blood pressure and heart rates were similar among groups (82±2 mmHg, 328±12.8 bpm). However, when we injected Ang II (50 ng in 1μl, ICV), there was a significant prolonged response in the recipient mice transferred with LPS-primed microglia compared to the ones receiving naïve controls (LPS 817±170 sec vs. control 475±70 sec; P<0.05 by unpaired T-test). This increase was fully abolished by co-incubation with minocycline, an inhibitor for microglial activation (LPS+minocycline 507±33 sec). There were no differences observed in pressure magnitude to ICV Ang II across the groups (11±2 mmHg). These data suggest that activated microglia alter neuronal plasticity and potentiate the neuronal responses to Ang II challenge. Taken together, microglial cells are activated, manifested by up-regulation of myeloid cell differentiation markers during hypertension, and then participate in the modulation of blood pressure.

Brain Cytokines As Neuromodulators In Cardiovascular Control

Brain Microglial Cytokines in Neurogenic Hypertension

Brain Transforming Growth Factor-Beta Resists Hypertension Via Regulating Microglial Activation

Microglia Participate in Neurogenic Regulation of Hypertension

Brain Microglial Cytokines are Critical for Renin-Angiotensin-Aldoterone-System(RAAS)-Induced Neurogenic Hypertension

Direct Pro-Inflammatory Effects of Prorenin on Microglia.

Involvement of the Brain (Pro) Renin Receptor in Cardiovascular Homeostasis

A1609 Microglia Regulate Sympathetic PVN Neuronal Activity in Both Resting and Hypertensive States

Abstract 208: Action of Multifaceted Microglia on Blood Pressure Control

Microglia, autonomic nervous system, immunity and hypertension: Is there a link?

The Brain-Heart Axis: Neuroinflammatory Interactions in Cardiovascular Disease

Brain Tumour Necrosis Factor-Alpha Modulates Neurotransmitters in Hypothalamic Paraventricular Nucleus in Heart Failure.

Neuroimmune modulation for targeting organ damage in hypertension and atherosclerosis

Cerebrovascular inflammation: A critical trigger for neurovascular injury?

Immunomodulatory Activity of Cytokines in Hypertension: A Vascular Perspective

Inflammatory Cytokines in Paraventricular Nucleus Modulate Sympathetic Activity and Cardiac Sympathetic Afferent Reflex in Rats

Cytokine Signaling Modulates Blood-Brain Barrier Function.

Cerebral Autoregulation in Hypertension and Ischemic Stroke: A Mini Review

Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Cardiovascular Diseases

The impact of cytokines in neuroinflammation-mediated stroke